ESTUTC-5 New YorkLog in Sign up

ABUS
Arbutus Biopharma Corporation Common Stock
stockNASDAQ

Market OpenNov 10, 2026 1:53:19 PM EST

3.80USD+2.151%(+0.08)1,117,132

Pre-marketNov 10, 2026 9:25:30 AM EST

3.71USD-0.269%(-0.01)

3.8000Bid3.8100Ask0.0100Spread

ABUS News

Day breaks

09:50 AM ESTArbutus Biopharma Reports Q3 2026 Earnings: EPS Hits $0.30, Revenue Falls to $0. ... ·

GuruFocus

08:09 AM ESTArbutus Biopharma earnings beat by $0.32, revenue fell short of estimates ·

Investing.com

07:33 AM ESTArbutus Biopharma GAAP EPS of $0.30 beats by $0.32, revenue of $0.3M misses by $0.7M ·

Seeking Alpha

07:30 AM ESTArbutus Reports Third Quarter 2026 Financial Results and Provides Corporate Update ·

GlobeNewswire Inc.

07:10 AM EDTHealthcare stocks with strong revenue growth and attractive valuations ·

Seeking Alpha

08:06 AM EDTWhy is Arbutus Biopharma stock climbing today? ·

Investing.com

07:30 AM EDTArbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor ·

GlobeNewswire Inc.+1 source

07:30 AM EDTArbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer ·

GlobeNewswire Inc.+1 source

12:51 PM EDTArbutus gains on plans to buy back 46M shares in tender offer ·

Seeking Alpha

07:30 AM EDTArbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer ·

GlobeNewswire Inc.

03:22 PM EDTNoteworthy Tuesday Option Activity: ALAB, ABUS, POR ·

BNK Invest